Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 50901-50950 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05369559
Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department
EARLY_PHASE1
Recruiting
1,000 participants
Started: Mar 3, 2022 · Completed: May 22, 2025
1 condition
1 sponsor
2 locations
NCT05223608
Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy
NA
Recruiting
500 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT05088863
Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging
NA
Recruiting
384 participants
Started: Mar 3, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05286931
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NA
Recruiting
1,800 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05166655
DBS Recordings to Characterize Movement Facilitation in Parkinson's Disease
NA
Recruiting
40 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05062369
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
NA
Recruiting
40 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT05545332
Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
N/A
Recruiting
600 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05068102
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
PHASE1
Recruiting
13 participants
Started: Mar 3, 2022 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT05154162
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
PHASE3
Recruiting
660 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2028
1 condition
2 sponsors
6 locations
NCT05285007
Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain
NA
Recruiting
60 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05608694
MRI Screening in Men at High Risk of Developing Prostate Cancer
NA
Recruiting
250 participants
Started: Mar 2, 2022 · Completed: Mar 1, 2039
1 condition
1 sponsor
2 locations
NCT05435248
Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
PHASE1/PHASE2
Recruiting
354 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05250648
Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
PHASE4
Recruiting
216 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2029
2 conditions
2 sponsors
31 locations
NCT04838522
A Study of Prucalopride in Breastfeeding Women With Constipation
N/A
Recruiting
12 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT05068908
Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders
N/A
Recruiting
95 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2026
3 conditions
1 sponsor
1 location
NCT05228431
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
PHASE2
Recruiting
121 participants
Started: Mar 2, 2022 · Completed: May 1, 2028
1 condition
1 sponsor
1 location
NCT05093764
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
NA
Recruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04049591
Higher vs. Lower Dose Heparin for PCI
NA
Recruiting
16,000 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT07087080
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NA
Recruiting
350 participants
Started: Mar 2, 2022 · Completed: Nov 1, 2027
2 conditions
2 sponsors
1 location
NCT05259930
Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis Patients
NA
Recruiting
130 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
2 conditions
2 sponsors
1 location
NCT04951817
68Ga-PSMA PET/CT for Ra223 Assessment
NA
Recruiting
52 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05142267
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
NA
Recruiting
120 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT06514079
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NA
Recruiting
21 participants
Started: Mar 2, 2022 · Completed: Aug 20, 2024
3 conditions
1 sponsor
1 location
NCT05082259
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
PHASE1
Recruiting
48 participants
Started: Mar 2, 2022 · Completed: Mar 16, 2026
3 conditions
4 sponsors
3 locations
NCT05207358
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
PHASE4
Recruiting
30 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05069038
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
PHASE2
Recruiting
46 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2031
1 condition
1 sponsor
1 location
NCT04973306
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
PHASE2/PHASE3
Recruiting
176 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
2 conditions
16 sponsors
1 location
NCT05050864
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NA
Recruiting
276 participants
Started: Mar 2, 2022 · Completed: Mar 15, 2027
3 conditions
1 sponsor
1 location
NCT05217940
Screening Women With Prior HPV for Anal Neoplasia
NA
Recruiting
300 participants
Started: Mar 2, 2022 · Completed: Jan 31, 2027
3 conditions
3 sponsors
3 locations
NCT05179733
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
PHASE3
Recruiting
280 participants
Started: Mar 2, 2022 · Completed: Dec 25, 2025
1 condition
29 sponsors
1 location
NCT04430517
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
EARLY_PHASE1
Recruiting
50 participants
Started: Mar 2, 2022 · Completed: Apr 30, 2025
2 conditions
2 sponsors
1 location
NCT05175248
Nutritional Intervention for Endometriosis
NA
Recruiting
120 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT04667078
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
PHASE3
Recruiting
368 participants
Started: Mar 2, 2022 · Completed: Jan 2, 2027
1 condition
2 sponsors
9 locations
NCT05090371
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
PHASE4
Recruiting
150 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
43 locations
NCT04905017
Trisol System EFS Study
NA
Recruiting
15 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
4 locations
NCT05597410
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
N/A
Recruiting
3,418 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2030
5 conditions
1 sponsor
1 location
NCT06626893
"Integrative Omics Approaches for Leukemia Target Identification and Matched Therapeutic Intervention"
NA
Recruiting
100 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2025
2 conditions
1 sponsor
8 locations
NCT05272696
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
PHASE2
Recruiting
86 participants
Started: Mar 1, 2022 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT05566054
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
PHASE2
Recruiting
92 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
2 conditions
8 sponsors
1 location
NCT05132439
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
PHASE3
Recruiting
200 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2031
1 condition
4 sponsors
1 location
NCT05199259
Multi-analyte Blood Test Clinical Trial
N/A
Recruiting
1,200 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2025
4 conditions
1 sponsor
7 locations
NCT06405464
Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures
N/A
Recruiting
600 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT06111989
Fitness to Drive Among Stroke Patients
N/A
Recruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT05167786
Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke
NA
Recruiting
115 participants
Started: Mar 1, 2022 · Completed: Aug 25, 2027
1 condition
2 sponsors
1 location
NCT05074381
Dry Needling of the M. Obliquus Capitis Inferior on Rotational Mobility and Headache Related Outcome Measures in CH.
NA
Recruiting
60 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06305858
Partial Versus Total Knee Replacement in Bicompartmental Gonarthrosis (Medial and Patellofemoral): Prospective Functional Assessment Study
NA
Recruiting
48 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05262673
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
PHASE1
Recruiting
10 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05297331
Renal Stone Treatment Global Registry
N/A
Recruiting
3,000 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2033
1 condition
1 sponsor
3 locations
NCT05124808
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NA
Recruiting
828 participants
Started: Mar 1, 2022 · Completed: Apr 8, 2026
3 conditions
6 sponsors
5 locations
NCT05251324
The Cardiovascular Impact of Hot Flushes
N/A
Recruiting
60 participants
Started: Mar 1, 2022 · Completed: May 26, 2026
2 conditions
1 sponsor
1 location
Previous
1
More pages
1016
1017
1018
1019
1020
1021
1022
More pages
1333
Next